PPCB vs W · P/E 0.0, $3.9M cap vs rev $11.85B
Propanc Biopharma, Inc. Common Stock (PPCB) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
PPCB does not have a complete income-statement cache yet.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. W currently screens at market cap $10.77B.
Not investment advice. Open the PPCB and W stock pages for the full models.
Not investment advice.